Atlas Trials

A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants

Clinical trial NCT06941077 · COMPLETED

Trial details

NCT number
NCT06941077
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2025-05-12
Primary completion
2025-06-03
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.